Randomized, Monocenter, Open Label, Two-way Cross-over, Single Dose Bioequivalence Study of Two Oral Formulations of Levetiracetam in Healthy Male and Female Japanese Subjects.
Phase of Trial: Phase I
Latest Information Update: 31 Oct 2014
At a glance
- Drugs Levetiracetam (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors UCB
- 29 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Oct 2009 New trial record